Pfizer Offers Government A "Not-For-Profit" Price For Roll-Out Of Its Two-Dose mRNA COVID-19 Vaccine In India

Pfizer Offers Government A "Not-For-Profit" Price For Roll-Out Of Its Two-Dose mRNA COVID-19 Vaccine In India
Pfizer logo (Pic Via Wikipedia)
United States (US) based pharmaceutical giant Pfizer said on Thursday (22 April) that it has offered a not-for-profit price for its COVID-19 vaccine to the Indian government and that it is in talks with the administration to deploy its vaccine for the ongoing nationwide inoculation drive, reports
Hindustan Times.
Pfizer in a collaboration with BioNTech has developed a two-dose mRNA vaccine that has been widely used in the US, Europe, Israel and other countries. The Pfizer Covid-19 vaccine has an efficacy of 95 per cent against the disease.

Related Keywords

Hindustan , India General , India , Japan , United States , United Kingdom , Israel , , Pfizer , European Union , Mrna Vaccine , Pfizer Biontech Vaccine , Covid 19 Vaccination Drive , Mrna Covid 19 Vaccine , Us Pharma Giant , ஹிந்துஸ்தான் , இந்தியா ஜநரல் , இந்தியா , ஜப்பான் , ஒன்றுபட்டது மாநிலங்களில் , ஒன்றுபட்டது கிஂக்டம் , இஸ்ரேல் , ஃபைசர் , ஐரோப்பிய தொழிற்சங்கம் , எங்களுக்கு பார்மா ராட்சத ,